TCL Archive DCT Board reluctantly Okays Resources Contracts Recompetition, $6 of $10 Million Competitively April 1, 1977
TCL Archive ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer October 9, 2009